疼痛管理薬の世界市場レポート 2025年

疼痛管理薬の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.0％で、1,065億6,000万米ドルに成長します。予測期間の成長は、非オピオイド代替薬、標的療法、精密医療アプローチ、心理学的介入、副作用の最小化に重点を置いた治療に起因すると考えられます。予測期間の主な動向には、価値に基づくケアモデル、拡大アクセスプログラム、併用療法、革新的な製剤、バイオシミラー鎮痛薬などが含まれます。

手術件数の増加が今後の疼痛管理薬市場の成長を押し上げると予想されます。外科手術とは、病気、状態、または怪我を治療するため、または身体機能を変更したり外観を改善したりするために、体の組織を切開または貫通する医療的介入を伴う手続きを指します。疼痛管理薬は、術後の痛みを制御・緩和し、患者の快適性と回復を大幅に向上させるため、手術には欠かせないものです。例えば、2023年9月、米国を拠点とする美容形成外科専門医の専門組織である国際美容形成外科学会（International Society of Aesthetic Plastic Surgery）は、Global Survey 2022報告書を発表し、2022年に形成外科医が行った手術が全体で11.2％増加し、世界中で合計1,490万件以上の手術が行われたことを明らかにしました。過去4年間、美容外科手術は一貫して増加しており、41.3％の増加を示しています。このように、手術件数の増加が疼痛管理薬市場の成長を牽引しています。

疼痛管理薬市場の成長は、高齢者人口の増加によってさらに後押しされると予想されます。高齢者人口は65歳以上で構成され、関節炎、がん、神経障害など、後期高齢者に多く見られる症状を緩和するために疼痛管理薬を必要とすることが多くあります。2022年10月の世界保健機関（WHO）の報告によると、2030年までに世界の6人に1人が60歳以上になり、2050年までに60歳以上の人口は21億人に倍増すると予測されています。さらに、2020～2050年の間に、80歳以上の高齢者は4億2,600万人増加します。こうした高齢化社会への人口動態の変化が、疼痛管理薬市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の疼痛管理薬市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の疼痛管理薬市場：成長率分析
• 世界の疼痛管理薬市場の実績：規模と成長、2019～2024年
• 世界の疼痛管理薬市場の予測：規模と成長、2024～2029年、2034年
• 世界の疼痛管理薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の疼痛管理薬市場：薬剤クラス別、実績と予測、2019～2024年、2024～2029年、2034年
• 非ステロイド性抗炎症薬（NSAID）
• 麻酔薬
• 抗てんかん薬
• 片頭痛治療薬
• 抗うつ薬
• オピオイド
• 非麻薬性鎮痛剤
• 世界の疼痛管理薬市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
• 関節痛
• 神経障害性疼痛
• がん性疼痛
• 慢性腰痛
• 術後疼痛
• 片頭痛
• 線維筋痛症
• 筋挫傷
• 骨折
• その他
• 世界の疼痛管理薬市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の疼痛管理薬市場：非ステロイド性抗炎症薬（NSAID）のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• イブプロフェン
• ナプロキセン
• アスピリン
• ジクロフェナク
• ケトロラク
• 世界の疼痛管理薬市場：麻酔薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 局所麻酔薬
• 全身麻酔薬
• 世界の疼痛管理薬市場：抗てんかん薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ガバペンチン
• プレガバリン
• カルバマゼピン
• トピラマート
• 世界の疼痛管理薬市場：片頭痛治療薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• トリプタン
• 麦角アルカロイド
• CGRP阻害剤
• 世界の疼痛管理薬市場：抗うつ剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 三環系抗うつ薬
• SNRI
• 世界の疼痛管理薬市場：オピオイドのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• モルヒネ
• オキシコドン
• ヒドロコドン
• フェンタニル
• 世界の疼痛管理薬市場：非麻薬性鎮痛剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• アセトアミノフェン
• アスピリン
• その他

第7章 地域別・国別分析

• 世界の疼痛管理薬市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の疼痛管理薬市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 疼痛管理薬市場：競合情勢
• 疼痛管理薬市場：企業プロファイル
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly And Company Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Endo International plc Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Merck & Co. Inc.
• Johnson & Johnson Services Inc.
• GlaxoSmithKline plc
• AbbVie Inc.
• Bristol-Myers Squibb Company
• Teva Pharmaceutical Industries Ltd.
• AstraZeneca plc
• Bausch Health Companies Inc.
• Sanofi
• F. Hoffmann-La Roche Ltd.
• Boehringer Ingelheim
• Mallinckrodt Pharmaceuticals
• Daiichi Sankyo Company Limited
• Grunenthal GmbH
• Mundipharma International Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 疼痛管理薬市場2029年：新たな機会を提供する国
• 疼痛管理薬市場2029年：新たな機会を提供するセグメント
• 疼痛管理薬市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A pain management drug is a medication designed to reduce pain, achieving analgesia through actions at multiple levels of the nervous system. These actions include the inhibition of neurotransmitter release from the primary afferent terminals in the spinal cord and the activation of descending inhibitory controls in the midbrain.

The primary classes of pain management drugs comprise non-steroidal anti-inflammatory drugs (NSAIDs), anesthetics, anticonvulsants, anti-migraine agents, antidepressants, opioids, and nonnarcotic analgesics. NSAIDs, or nonsteroidal anti-inflammatory drugs, are specifically designed to lower a high fever, reduce inflammation, and alleviate discomfort. They find application in various conditions such as arthritic pain, neuropathic pain, cancer pain, chronic back pain, postoperative pain, migraine, fibromyalgia, muscle sprain/strain, bone fractures, among others. These drugs are distributed through different channels including hospital pharmacies, retail pharmacies, and online pharmacies.

The pain management drugs market research report is one of a series of new reports from The Business Research Company that provides pain management drugs market statistics, including pain management drugs industry global market size, regional shares, competitors with a pain management drugs market share, detailed pain management drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the pain management drugs industry. This pain management drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pain management drugs market size has grown strongly in recent years. It will grow from $80.13 billion in 2024 to $84.51 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to rising chronic pain cases, rise in cancer cases, increased surgical procedures, improved pain assessment, government initiatives.

The pain management drugs market size is expected to see strong growth in the next few years. It will grow to $106.56 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to non-opioid alternatives, targeted therapies, precision medicine approaches, psychological interventions, focus on minimizing side effects. Major trends in the forecast period include value-based care models, expanded access programs, combination therapies, innovative formulations, biosimilar pain drugs.

An increasing number of surgeries is anticipated to boost the growth of the pain management drugs market in the future. A surgical procedure involves medical intervention that requires cutting or penetrating the body's tissues to treat diseases, conditions, or injuries, or to alter bodily functions or enhance appearance. Pain management drugs are essential in surgeries as they help control and alleviate post-operative pain, significantly enhancing patient comfort and recovery. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a US-based professional organization for board-certified aesthetic plastic surgeons, released the Global Survey 2022 report, which revealed an 11.2% overall increase in procedures performed by plastic surgeons in 2022, totaling over 14.9 million surgical procedures worldwide. There has been a consistent rise in aesthetic surgery over the past four years, showing a 41.3% increase. Therefore, the rising rate of surgeries is driving the growth of the pain management drugs market.

The growth of the pain management drugs market is further expected to be boosted by the rise in the geriatric population. The geriatric population, comprising individuals aged 65 and older, often requires pain management drugs to alleviate conditions such as arthritis, cancer, and neurological disorders that are more prevalent in later life. According to a report by the World Health Organization (WHO) in October 2022, it is projected that by 2030, one in six individuals globally will be 60 years or older, and the number of individuals over 60 will double to 2.1 billion by 2050. Additionally, between 2020 and 2050, there will be an increase of 426 million people aged 80 or older. This demographic shift toward an aging population is a driving force behind the growth of the pain management drugs market.

Technological advancement is a prominent trend gaining traction in the pain management drugs market. Major companies in this sector are concentrating on the development of new technologies. For example, in October 2024, Vertex Pharmaceuticals, a US-based biotechnology firm, announced substantial progress in Suzetrigine (VX-548) for treating acute and neuropathic pain. This innovative medication aims to deliver effective pain relief while minimizing the side effects typically associated with conventional analgesics. The development of Suzetrigine is expected to expand treatment options for patients experiencing various pain conditions, thereby enhancing their quality of life. By advancing this cutting-edge therapy, Vertex seeks to address unmet medical needs in pain management and establish itself as a leader in the pharmaceutical industry.

Major companies in the pain management drugs market are developing drugs and obtaining FDA approval. FDA approval, indicating adherence to safety and efficacy standards, is crucial for commercial distribution in the United States. For instance, in October 2023, Hyloris Pharmaceuticals, a Belgium-based pharmaceutical company, received FDA approval for Maxigesic IV. This non-opioid intravenous painkiller, combining paracetamol and ibuprofen, offers a dual-action mechanism for pain relief and represents a significant advancement in the market, providing a new non-opioid treatment option for post-operative pain relief.

In October 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology firm, acquired Biohaven Pharmaceuticals Inc. for an undisclosed sum. This acquisition is intended to strengthen Pfizer's portfolio in the neurology sector, specifically focusing on the development and commercialization of innovative treatments for neurological disorders. Biohaven Pharmaceuticals Inc. is a US-based biotechnology research company specializing in the development of pain management drugs.

Major companies operating in the pain management drugs market include Novartis AG, Eli Lilly And Company, Abbott Laboratories, Endo International plc, Pfizer Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., GlaxoSmithKline plc, AbbVie Inc., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Bausch Health Companies Inc., Sanofi, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim, Mallinckrodt Pharmaceuticals, Daiichi Sankyo Company Limited, Grunenthal GmbH, Mundipharma International Limited, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Zydus Cadila, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd.

North America was the largest region in the pain management drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the pain management drug market report during the forecast period. The regions covered in the pain management drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pain management drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pain management drug market consists of sales of acetaminophen, anti-seizure medications, steroids, muscle relaxers, and other related drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pain Management Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pain management drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pain management drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pain management drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Anesthetics; Anticonvulsants; Anti-Migraine Agents; Antidepressants; Opioids; Nonnarcotic Analgesics
• 2) By Indication: Arthritic Pain; Neuropathic Pain; Cancer Pain; Chronic Back Pain; Postoperative Pain; Migraine; Fibromyalgia; Muscle Sprain Or Strain; Bone Fracture; Other Indications
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen; Naproxen; Aspirin; Diclofenac; Ketorolac
• 2) By Anesthetics: Local Anesthetics; General Anesthetics
• 3) By Anticonvulsants: Gabapentin; Pregabalin; Carbamazepine; Topiramate
• 4) By Anti-Migraine Agents: Triptans; Ergot Alkaloids; CGRP Inhibitors
• 5) By Antidepressants: Tricyclic Antidepressants; SNRIs
• 6) By Opioids: Morphine; Oxycodone; Hydrocodone; Fentanyl
• 7) By Nonnarcotic Analgesics: Acetaminophen; Aspirin; Other Analgesics
• Companies Mentioned: Novartis AG; Eli Lilly And Company; Abbott Laboratories; Endo International plc; Pfizer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pain Management Drugs Market Characteristics

3. Pain Management Drugs Market Trends And Strategies

4. Pain Management Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pain Management Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pain Management Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pain Management Drugs Market Growth Rate Analysis
• 5.4. Global Pain Management Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pain Management Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pain Management Drugs Total Addressable Market (TAM)

6. Pain Management Drugs Market Segmentation

• 6.1. Global Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Anesthetics
• Anticonvulsants
• Anti-migraine Agents
• Antidepressants
• Opioids
• Nonnarcotic Analgesics
• 6.2. Global Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Arthritic Pain
• Neuropathic Pain
• Cancer Pain
• Chronic Back Pain
• Postoperative Pain
• Migraine
• Fibromyalgia
• Muscle sprain/strain
• Bone fracture
• Other Indications
• 6.3. Global Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Pain Management Drugs Market, Sub-Segmentation Of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ibuprofen
• Naproxen
• Aspirin
• Diclofenac
• Ketorolac
• 6.5. Global Pain Management Drugs Market, Sub-Segmentation Of Anesthetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Local Anesthetics
• General Anesthetics
• 6.6. Global Pain Management Drugs Market, Sub-Segmentation Of Anticonvulsants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gabapentin
• Pregabalin
• Carbamazepine
• Topiramate
• 6.7. Global Pain Management Drugs Market, Sub-Segmentation Of Anti-Migraine Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Triptans
• Ergot Alkaloids
• CGRP Inhibitors
• 6.8. Global Pain Management Drugs Market, Sub-Segmentation Of Antidepressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tricyclic Antidepressants
• SNRIs
• 6.9. Global Pain Management Drugs Market, Sub-Segmentation Of Opioids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Morphine
• Oxycodone
• Hydrocodone
• Fentanyl
• 6.10. Global Pain Management Drugs Market, Sub-Segmentation Of Nonnarcotic Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acetaminophen
• Aspirin
• Other Analgesics

7. Pain Management Drugs Market Regional And Country Analysis

• 7.1. Global Pain Management Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pain Management Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pain Management Drugs Market

• 8.1. Asia-Pacific Pain Management Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pain Management Drugs Market

• 9.1. China Pain Management Drugs Market Overview
• 9.2. China Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pain Management Drugs Market

• 10.1. India Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pain Management Drugs Market

• 11.1. Japan Pain Management Drugs Market Overview
• 11.2. Japan Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pain Management Drugs Market

• 12.1. Australia Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pain Management Drugs Market

• 13.1. Indonesia Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pain Management Drugs Market

• 14.1. South Korea Pain Management Drugs Market Overview
• 14.2. South Korea Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pain Management Drugs Market

• 15.1. Western Europe Pain Management Drugs Market Overview
• 15.2. Western Europe Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pain Management Drugs Market

• 16.1. UK Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pain Management Drugs Market

• 17.1. Germany Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pain Management Drugs Market

• 18.1. France Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pain Management Drugs Market

• 19.1. Italy Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pain Management Drugs Market

• 20.1. Spain Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pain Management Drugs Market

• 21.1. Eastern Europe Pain Management Drugs Market Overview
• 21.2. Eastern Europe Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pain Management Drugs Market

• 22.1. Russia Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pain Management Drugs Market

• 23.1. North America Pain Management Drugs Market Overview
• 23.2. North America Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pain Management Drugs Market

• 24.1. USA Pain Management Drugs Market Overview
• 24.2. USA Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pain Management Drugs Market

• 25.1. Canada Pain Management Drugs Market Overview
• 25.2. Canada Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pain Management Drugs Market

• 26.1. South America Pain Management Drugs Market Overview
• 26.2. South America Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pain Management Drugs Market

• 27.1. Brazil Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pain Management Drugs Market

• 28.1. Middle East Pain Management Drugs Market Overview
• 28.2. Middle East Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pain Management Drugs Market

• 29.1. Africa Pain Management Drugs Market Overview
• 29.2. Africa Pain Management Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pain Management Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pain Management Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pain Management Drugs Market Competitive Landscape And Company Profiles

• 30.1. Pain Management Drugs Market Competitive Landscape
• 30.2. Pain Management Drugs Market Company Profiles
  • 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eli Lilly And Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Endo International plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pain Management Drugs Market Other Major And Innovative Companies

• 31.1. Merck & Co. Inc.
• 31.2. Johnson & Johnson Services Inc.
• 31.3. GlaxoSmithKline plc
• 31.4. AbbVie Inc.
• 31.5. Bristol-Myers Squibb Company
• 31.6. Teva Pharmaceutical Industries Ltd.
• 31.7. AstraZeneca plc
• 31.8. Bausch Health Companies Inc.
• 31.9. Sanofi
• 31.10. F. Hoffmann-La Roche Ltd.
• 31.11. Boehringer Ingelheim
• 31.12. Mallinckrodt Pharmaceuticals
• 31.13. Daiichi Sankyo Company Limited
• 31.14. Grunenthal GmbH
• 31.15. Mundipharma International Limited

32. Global Pain Management Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pain Management Drugs Market

34. Recent Developments In The Pain Management Drugs Market

35. Pain Management Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Pain Management Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pain Management Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pain Management Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer